Interleukin-18 as a potential therapeutic target in chronic autoimmune/inflammatory conditions

Bibliography

• SUGAWARA S, UEHARA A, NOCHI T et al.: Neutrophil proteinase 3-mediated induction of bioactive IL-18 secretion by human oral epithelial cells. J. Immunol. (2001) 167(11):6568-6575.
   PubMed Web of Science ®Google Scholar
• DINARELLO CA: Targeting interleukin 18 with interleukin 18 binding protein. Ann. Rheum. Dis. (2000) 59(Suppl. 1):i17-i20.
   PubMed Web of Science ®Google Scholar
• OKAMURA H, NAGATA K, KOMATSU T et al.: A novel costimulatory factor for gamma interferon induction found in the livers of mice causes endotoxic shock. Infect. Immun. (1995) 63(10):3966-3972.
   PubMed Web of Science ®Google Scholar
• TAKEDA K, TSUTSUI H, YOSHIMOTO T et al.: Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity (1998) 8(3):383-390.
   PubMed Web of Science ®Google Scholar
• OKAMURA H, KASHIWAMURA S, TSUTSUI H, YOSHIMOTO T, NAKANISHI K: Regulation of interferon-gamma production by IL-12 and IL-18. Curr. Opin. Immunol. (1998) 10(3):259-264.
   PubMed Web of Science ®Google Scholar
• NAKANISHI K, YOSHIMOTO T, TSUTSUI H, OKAMURA H: Interleukin-18 regulates both Th1 and Th2 responses. Annu. Rev. Immunol. (2001) 19:423-474.
   PubMed Web of Science ®Google Scholar
• XU D, CHAN WL, LEUNG BP et al.: Selective expression and functions of interleukin 18 receptor on T helper (Th) Type 1 but not Th2 cells. J. Exp. Med. (1998) 188(8):1485-1492.
   PubMed Web of Science ®Google Scholar
• DINARELLO CA, NOVICK D, PUREN AJ et al.: Overview of interleukin-18: more than an interferon-gamma inducing factor. J. Leukoc. Biol. (1998) 63(6):658-664.
   PubMed Web of Science ®Google Scholar
• GRACIE JA, FORSEY RJ, CHAN WL et al.: A proinflammatory role for IL-18 in rheumatoid arthritis. J. Clin. Invest. (1999) 104(10):1393-1401.
   PubMed Web of Science ®Google Scholar
• MCINNES IB, GRACIE JA, LEUNG BP, WEI XQ, LIEW FY: Interleukin 18: a pleiotropic participant in chronic inflammation. Immunol. Today (2000) 21(7):312-315.
   PubMedGoogle Scholar
• PUREN AJ, FANTUZZI G, GU Y, SU MS, DINARELLO CA: Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells. J. Clin. Invest. (1998) 101(3):711-721.
   PubMed Web of Science ®Google Scholar
• HOSHINO T, YAGITA H, ORTALDO JR, WILTROUT RH, YOUNG HA: In vivo administration of IL-18 can induce IgE production through Th2 cytokine induction and up-regulation of CD40 ligand (CD154) expression on CD4+ T cells. Eur. J. Immunol. (2000) 30(7):1998-2006.
   PubMed Web of Science ®Google Scholar
• TAKAHASHI HK, IWAGAKI H, YOSHINO T et al.: Prostaglandin E(2) inhibits IL-18-induced ICAM-1 and B7.2 expression through EP2/EP4 receptors in human peripheral blood mononuclear cells. J. Immunol. (2002) 168(9):4446-4454.
   PubMed Web of Science ®Google Scholar
• DAO T, OHASHI K, KAYANO T, KURIMOTO M, OKAMURA H: Interferon-gamma-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cells. Cell. Immunol. (1996) 173(2):230-235.
   PubMed Web of Science ®Google Scholar
• HYODO Y, MATSUI K, HAYASHI N et al.: IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor. J. Immunol. (1999) 162(3):1662-1668.
   PubMed Web of Science ®Google Scholar
• DAO T, MEHAL WZ, CRISPE IN: IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells. J. Immunol. (1998) 161(5):2217-2222.
   PubMed Web of Science ®Google Scholar
• TSUTSUI H, NAKANISHI K, MATSUI K et al.: IFN-gamma-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. J. Immunol. (1996) 157(9):3967-3973.
   PubMed Web of Science ®Google Scholar
• MOLLER B, KESSLER U, REHART S et al.: Expression of interleukin-18 receptor in fibroblast-like synoviocytes. Arthritis Res. (2002) 4(2):139-144.
   PubMedGoogle Scholar
• GERDES N, SUKHOVA GK, LIBBY P, REYNOLDS RS, YOUNG JL, SCHONBECK U: Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis. J. Exp. Med. (2002) 195(2):245-257.
   PubMed Web of Science ®Google Scholar
• SEMINO C, ANGELINI G, POGGI A, RUBARTELLI A: NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1. Blood (2005) 106(2):609-616.
   PubMed Web of Science ®Google Scholar
• MAILLIARD RB, ALBER SM, SHEN H et al.: IL-18-induced CD83+CCR7+ NK helper cells. J. Exp. Med. (2005) 202(7):941-953.
   PubMed Web of Science ®Google Scholar
• MOLLER B, KUKOC-ZIVOJNOV N, KESSLER U et al.: Expression of interleukin-18 and its monokine-directed function in rheumatoid arthritis. Rheumatology (Oxford) (2001) 40(3):302-309.
   PubMed Web of Science ®Google Scholar
• YAMAMURA M, KAWASHIMA M, TANIAI M et al.: Interferon-gamma-inducing activity of interleukin-18 in the joint with rheumatoid arthritis. Arthritis Rheum. (2001) 44(2):275-285.
   PubMed Web of Science ®Google Scholar
• MOREL JC, PARK CC, ZHU K, KUMAR P, RUTH JH, KOCH AE: Signal transduction pathways involved in rheumatoid arthritis synovial fibroblast interleukin-18-induced vascular cell adhesion molecule-1 expression. J. Biol. Chem. (2002) 277(38):34679-34691.
   PubMed Web of Science ®Google Scholar
• MOREL JC, PARK CC, KUMAR P, KOCH AE: Interleukin-18 induces rheumatoid arthritis synovial fibroblast CXC chemokine production through NFkappaB activation. Lab. Invest. (2001) 81(10):1371-1383.
   PubMed Web of Science ®Google Scholar
• CHO ML, JUNG YO, MOON YM et al.: Interleukin-18 induces the production of vascular endothelial growth factor (VEGF) in rheumatoid arthritis synovial fibroblasts via AP-1-dependent pathways. Immunol. Lett. (2006) 103(2):159-166.
   PubMed Web of Science ®Google Scholar
• JOOSTEN LA, RADSTAKE TR, LUBBERTS E et al.: Association of interleukin-18 expression with enhanced levels of both interleukin-1beta and tumor necrosis factor alpha in knee synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum. (2003) 48(2):339-347.
   PubMed Web of Science ®Google Scholar
• PITTONI V, BOMBARDIERI M, SPINELLI FR et al.: Anti-tumour necrosis factor (TNF) alpha treatment of rheumatoid arthritis (infliximab) selectively down regulates the production of interleukin (IL) 18 but not of IL12 and IL13. Ann. Rheum. Dis. (2002) 61(8):723-725.
   PubMed Web of Science ®Google Scholar
• VAN OOSTERHOUT M, LEVARHT EW, SONT JK, HUIZINGA TW, TOES RE, VAN LAAR JM: Clinical efficacy of infliximab plus methotrexate in DMARD naive and DMARD refractory rheumatoid arthritis is associated with decreased synovial expression of TNF alpha and IL18 but not CXCL12. Ann. Rheum. Dis. (2005) 64(4):537-543.
   PubMed Web of Science ®Google Scholar
• PARK CC, MOREL JC, AMIN MA, CONNORS MA, HARLOW LA, KOCH AE: Evidence of IL-18 as a novel angiogenic mediator. J. Immunol. (2001) 167(3):1644-1653.
   PubMed Web of Science ®Google Scholar
• OLEE T, HASHIMOTO S, QUACH J, LOTZ M: IL-18 is produced by articular chondrocytes and induces proinflammatory and catabolic responses. J. Immunol. (1999) 162(2):1096-1100.
   PubMed Web of Science ®Google Scholar
• KAPLAN MJ: Cardiovascular disease in rheumatoid arthritis. Curr. Opin. Rheumatol. (2006) 18(3):289-297.
   PubMed Web of Science ®Google Scholar
• SATTAR N, MCINNES IB: Vascular comorbidity in rheumatoid arthritis: potential mechanisms and solutions. Curr. Opin. Rheumatol. (2005) 17(3):286-292.
   PubMed Web of Science ®Google Scholar
• MALLAT Z, CORBAZ A, SCOAZEC A et al.: Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation (2001) 104(14):1598-1603.
   PubMed Web of Science ®Google Scholar
• MALLAT Z, CORBAZ A, SCOAZEC A et al.: Interleukin-18/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability. Circ. Res. (2001) 89(7):E41-E45.
   PubMed Web of Science ®Google Scholar
• WHITMAN SC, RAVISANKAR P, DAUGHERTY A: Interleukin-18 enhances atherosclerosis in apolipoprotein E(-/-) mice through release of interferon-gamma. Circ. Res. (2002) 90(2):E34-E38.
   PubMed Web of Science ®Google Scholar
• TIRET L, GODEFROY T, LUBOS E et al.: Genetic analysis of the interleukin-18 system highlights the role of the interleukin-18 gene in cardiovascular disease. Circulation (2005) 112(5):643-650.
   PubMed Web of Science ®Google Scholar
• BLANKENBERG S, TIRET L, BICKEL C et al.: Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation (2002) 106(1):24-30.
   PubMed Web of Science ®Google Scholar
• LEUNG BP, MCINNES IB, ESFANDIARI E, WEI XQ, LIEW FY: Combined effects of IL-12 and IL-18 on the induction of collagen-induced arthritis. J. Immunol. (2000) 164(12):6495-6502.
   PubMed Web of Science ®Google Scholar
• WEI XQ, LEUNG BP, ARTHUR HM, MCINNES IB, LIEW FY: Reduced incidence and severity of collagen-induced arthritis in mice lacking IL-18. J. Immunol. (2001) 166(1):517-521.
   PubMed Web of Science ®Google Scholar
• PLATER-ZYBERK C, JOOSTEN LA, HELSEN MM et al.: Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritis. J. Clin. Invest. (2001) 108(12):1825-1832.
   PubMed Web of Science ®Google Scholar
• BANDA NK, VONDRACEK A, KRAUS D et al.: Mechanisms of inhibition of collagen-induced arthritis by murine IL-18 binding protein. J. Immunol. (2003) 170(4):2100-2105.
   PubMed Web of Science ®Google Scholar
• SMEETS RL, VAN DE LOO FA, ARNTZ OJ, BENNINK MB, JOOSTEN LA, VAN DEN BERG WB: Adenoviral delivery of IL-18 binding protein C ameliorates collagen-induced arthritis in mice. Gene Ther. (2003) 10(12):1004-1011.
   PubMed Web of Science ®Google Scholar
• MONTELEONE G, TRAPASSO F, PARRELLO T et al.: Bioactive IL-18 expression is up-regulated in Crohn’s disease. J. Immunol. (1999) 163(1):143-147.
   PubMed Web of Science ®Google Scholar
• PIZARRO TT, MICHIE MH, BENTZ M et al.: IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn’s disease: expression and localization in intestinal mucosal cells. J. Immunol. (1999) 162(11):6829-6835.
   PubMed Web of Science ®Google Scholar
• TAMURA K, FUKUDA Y, SASHIO H et al.: IL18 polymorphism is associated with an increased risk of Crohn’s disease. J. Gastroenterol. (2002) 37(Suppl. 14):111-116.
   PubMed Web of Science ®Google Scholar
• AIZAWA Y, SUTOH S, MATSUOKA M et al.: Association of interleukin-18 gene single-nucleotide polymorphisms with susceptibility to inflammatory bowel disease. Tissue Antigens (2005) 65(1):88-92.
   PubMed Web of Science ®Google Scholar
• GLAS J, TOROK HP, TONENCHI L et al.: Association of polymorphisms in the interleukin-18 gene in patients with Crohn’s disease depending on the CARD15/NOD2 genotype. Inflamm. Bowel. Dis. (2005) 11(12):1031-1037.
   PubMed Web of Science ®Google Scholar
• KANAI T, WATANABE M, OKAZAWA A et al.: Macrophage-derived IL-18-mediated intestinal inflammation in the murine model of Crohn’s disease. Gastroenterology (2001) 121(4):875-888.
   PubMed Web of Science ®Google Scholar
• TEN HOVE T, CORBAZ A, AMITAI H et al.: Blockade of endogenous IL-18 ameliorates TNBS-induced colitis by decreasing local TNF-alpha production in mice. Gastroenterology (2001) 121(6):1372-1379.
   PubMed Web of Science ®Google Scholar
• SIEGMUND B, FANTUZZI G, RIEDER F et al.: Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-gamma and TNF-alpha production. Am. J. Physiol Regul. Integr. Comp. Physiol. (2001) 281(4):R1264-R1273.
   PubMed Web of Science ®Google Scholar
• REUTER BK, PIZARRO TT: Commentary: the role of the IL-18 system and other members of the IL-1R/TLR superfamily in innate mucosal immunity and the pathogenesis of inflammatory bowel disease: friend or foe? Eur. J. Immunol. (2004) 34(9):2347-2355.
   PubMed Web of Science ®Google Scholar
• BOMBARDIERI M, BARONE F, PITTONI V et al.: Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjogren’s syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate. Arthritis Res. Ther. (2004) 6(5):R447-R456.
   PubMed Web of Science ®Google Scholar
• ERIKSSON P, ANDERSSON C, EKERFELT C, ERNERUDH J, SKOGH T: Relationship between serum levels of IL-18 and IgG1 in patients with primary Sjogren’s syndrome, rheumatoid arthritis and healthy controls. Clin. Exp. Immunol. (2004) 137(3):617-620.
   PubMed Web of Science ®Google Scholar
• MANOUSSAKIS MN: Immunological and clinical predictors for lymphoma in Sjogren’s syndrome. Ann. Rheum. Dis. (2006) 65(Suppl. 11):6-7.
   Google Scholar
• FAUST J, MENKE J, KRIEGSMANN J et al.: Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis. Arthritis Rheum. (2002) 46(11):3083-3095.
   PubMed Web of Science ®Google Scholar
• ESFANDIARI E, MCINNES IB, LINDOP G et al.: A proinflammatory role of IL-18 in the development of spontaneous autoimmune disease. J. Immunol. (2001) 167(9):5338-5347.
   PubMed Web of Science ®Google Scholar
• ROTHE H, JENKINS NA, COPELAND NG, KOLB H: Active stage of autoimmune diabetes is associated with the expression of a novel cytokine, IGIF, which is located near Idd2. J. Clin. Invest. (1997) 99(3):469-474.
   PubMed Web of Science ®Google Scholar
• ROTHE H, HIBINO T, ITOH Y, KOLB H, MARTIN S: Systemic production of interferon-gamma inducing factor (IGIF) versus local IFN-gamma expression involved in the development of Th1 insulitis in NOD mice. J. Autoimmun. (1997) 10(3):251-256.
   PubMed Web of Science ®Google Scholar
• BOMBARDIERI M, BARONE F, CARLUCCI F, VALESINI G, MCINNES IB, PITZALIS C: The IL-18/IL-18R axis is significantly up-regulated in sumbandibular glands in the NOD mouse model of Sjogren’s syndrome and is associated with an ongoing Th1-mediated inflammation. Ann. Rheum. Dis. (2006) 65(Suppl. 11):105-106.
   PubMedGoogle Scholar
• KAWASHIMA M, YAMAMURA M, TANIAI M et al.: Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still’s disease. Arthritis Rheum. (2001) 44(3):550-560.
   PubMed Web of Science ®Google Scholar
• KAWAGUCHI Y, TERAJIMA H, HARIGAI M, HARA M, KAMATANI N: Interleukin-18 as a novel diagnostic marker and indicator of disease severity in adult-onset Still’s disease. Arthritis Rheum. (2001) 44(7):1716-1717.
   PubMed Web of Science ®Google Scholar
• SUGIURA T, KAWAGUCHI Y, HARIGAI M et al.: Association between adult-onset Still’s disease and interleukin-18 gene polymorphisms. Genes Immun. (2002) 3(7):394-399.
   PubMed Web of Science ®Google Scholar
• OHTA Y, HAMADA Y, KATSUOKA K: Expression of IL-18 in psoriasis. Arch. Dermatol. Res. (2001) 293(7):334-342.
   PubMed Web of Science ®Google Scholar
• UYEMURA K, YAMAMURA M, FIVENSON DF, MODLIN RL, NICKOLOFF BJ: The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper Type 1 cell-mediated response. J. Invest. Dermatol. (1993) 101(5):701-705.
   Google Scholar
• NAIK SM, CANNON G, BURBACH GJ et al.: Human keratinocytes constitutively express interleukin-18 and secrete biologically active interleukin-18 after treatment with pro-inflammatory mediators and dinitrochlorobenzene. J. Invest. Dermatol. (1999) 113(5):766-772.
   Google Scholar
• GUTZMER R, LANGER K, MOMMERT S, WITTMANN M, KAPP A, WERFEL T: Human dendritic cells express the IL-18R and are chemoattracted to IL-18. J. Immunol. (2003) 171(12):6363-6371.
   PubMed Web of Science ®Google Scholar
• WITTMANN M, PURWAR R, HARTMANN C, GUTZMER R, WERFEL T: Human keratinocytes respond to interleukin-18: implication for the course of chronic inflammatory skin diseases. J. Invest. Dermatol. (2005) 124(6):1225-1233.
   Google Scholar
• ROONEY T, MURPHY E, BENITO M et al.: Synovial tissue interleukin-18 expression and the response to treatment in patients with inflammatory arthritis. Ann. Rheum. Dis. (2004) 63(11):1393-1398.
   PubMed Web of Science ®Google Scholar
• VAN KUIJK AW, REINDERS-BLANKERT P, SMEETS TJ, DIJKMANS BA, TAK PP: Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for therapy. Ann. Rheum. Dis. (2006) 65(12):1551-1557.
   PubMed Web of Science ®Google Scholar
• DINARELLO CA, FANTUZZI G: Interleukin-18 and host defense against infection. J. Infect. Dis. (2003) 187(Suppl. 2):S370-S384.
   PubMed Web of Science ®Google Scholar
• LOGAN TF, ROBERTSON MJ: Interleukins 18 and 21: biology, mechanisms of action, toxicity, and clinical activity. Curr. Oncol. Rep. (2006) 8(2):114-119.
   PubMedGoogle Scholar
• HWANG KS, CHO WK, YOO J et al.: Adenovirus-mediated interleukin-18 mutant in vivo gene transfer inhibits tumor growth through the induction of T cell immunity and activation of natural killer cell cytotoxicity. Cancer Gene Ther. (2004) 11(6):397-407.
   PubMed Web of Science ®Google Scholar
• GOLAB J, STOKLOSA T: Technology evaluation: SB-485232, GlaxoSmithKline. Curr. Opin. Mol. Ther. (2005) 7(1):85-93.
   PubMed Web of Science ®Google Scholar